rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Nexavar

Rediff.com  »  News  »   Nexavar

  News for Nexavar

  • Business

Bayer to appeal against patent order on Nexavar

Bayer AG has said it will approach the high court in Mumbai against a ruling by Intellectual Property Appellate Board that upheld the compulsory licence issued to India's Natco Pharma to make and......

India must act fast to frame new IPR policy

Even as India prepares to sit for the first high-level dialogue on intellectual property rights (IPR) law and patents with the US on Monday, work on rolling out a 'National IPR Policy' has been......

3 Indian pharma firms named in US Congress price probe

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months The US Congress seems to have gone on the offensive against 14 generic drug manufacturers, including three......

US maintains status quo on India's patent regime

In its much-awaited Annual Special 301 Report, the US Trade Representative on Wednesday maintained status quo on India, by keeping it on a “priority watch list” for an allegedly lax......

PM urged to reject US pressure tactics on trade, biz policies

A group of India and American no-profit organisations and other groups have urged the Prime Minister, Manmohan Singh, not to succumb to the pressure of the US administration and reject the......
  Web results for Nexavar
Commerce Ministry considering proposal for CL to anti-cancer drug

Commerce and Industry Minister Nirmala Sitharaman said the matter was examined. Photo: Bloomberg New Delhi: The Ministry of Commerce and... ...

http://www.livemint.com/Politics/xr2ilPf1kJIDNzwzK07nrO/Commerce-Ministry-considering-proposal-for-CL-to-anticancer.html
Positive Results of Clinical Trials - Report on TRACON Pharmaceuticals

TRACON PHARMACEUTICALS, INC. (NASDAQ:TCON) Intraday Stock Chart Today : Wednesday 22 July 2015 NEW YORK , July 22, 2015 /PRNewswire/ --... ...

http://in.advfn.com/p.php?pid=nmona&article=67825090
AstraZeneca

MNC reviewing options on Lee Pharma's CL In a statement reacting to Lee Pharma's application for a compulsory license (CL) for saxagliptin,... ...

http://www.financialexpress.com/article/pharma/market-pharma/confident-in-our-ip-astrazeneca/104895/
Lee Pharma revives the CL debate

With little known Lee Pharma filing India's third compulsory licensing (CL), legal eagles and everyone interested or connected to pharmaceutical IP... ...

http://www.financialexpress.com/article/pharma/editors-note/lee-pharma-revives-the-cl-debate/104383/
Sorafenib Patent Search and China Sorafenib Market 2010-2019 Size Reviewed in New Research Reports

From the Wires Jul. 14, 2015 02:00 AM DALLAS, July 14, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Investigation Report on China... ...

http://in.sys-con.com/node/3366031

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z